Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia
出版年份 2017 全文链接
标题
Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia
作者
关键词
-
出版物
JOURNAL OF NEUROCHEMISTRY
Volume 142, Issue 5, Pages 756-766
出版商
Wiley
发表日期
2017-06-19
DOI
10.1111/jnc.14104
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l -DOPA treatment and changes in levodopa-induced dyskinesia
- (2017) Andreas Dammann Andersen et al. JOURNAL OF NEUROCHEMISTRY
- Kynurenine pathway metabolism and the microbiota-gut-brain axis
- (2017) P.J. Kennedy et al. NEUROPHARMACOLOGY
- Involvement of the kynurenine pathway in the pathogenesis of Parkinson’s disease
- (2017) Chai K. Lim et al. PROGRESS IN NEUROBIOLOGY
- Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry
- (2017) Philippe De Deurwaerdère et al. PROGRESS IN NEUROBIOLOGY
- 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA
- (2016) Masato Asanuma et al. BMC NEUROSCIENCE
- Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
- (2016) Jens O. Watzlawik et al. CURRENT PHARMACEUTICAL DESIGN
- Central kynurenine pathway shift with age in women
- (2016) Josien de Bie et al. JOURNAL OF NEUROCHEMISTRY
- Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects
- (2016) Anna Wuolikainen et al. Molecular BioSystems
- Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain
- (2016) Airi Sekine et al. NEUROCHEMICAL RESEARCH
- Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites
- (2016) Carlo Breda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis
- (2016) Michael D. Lovelace et al. Frontiers in Immunology
- Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
- (2015) Taku Hatano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder
- (2015) C M Sellgren et al. MOLECULAR PSYCHIATRY
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder
- (2015) Jonathan Savitz et al. PSYCHONEUROENDOCRINOLOGY
- Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia
- (2015) Francesco Fazio et al. Scientific Reports
- Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson’s disease
- (2015) Hemi Luan et al. Scientific Reports
- LC–MS-Based Urinary Metabolite Signatures in Idiopathic Parkinson’s Disease
- (2014) Hemi Luan et al. JOURNAL OF PROTEOME RESEARCH
- Stress-Induced Increase in Kynurenic Acid as a Potential Biomarker for Patients With Schizophrenia and Distress Intolerance
- (2014) Joshua Chiappelli et al. JAMA Psychiatry
- The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1 and with increased CSF KYNA level and reduced KMO expression
- (2013) C Lavebratt et al. MOLECULAR PSYCHIATRY
- 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson’s Disease: a Pilot Study
- (2013) James R. Roede et al. PLoS One
- Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder
- (2012) Sara K Olsson et al. BIPOLAR DISORDERS
- Kynurenines in the CNS: recent advances and new questions
- (2012) László Vécsei et al. NATURE REVIEWS DRUG DISCOVERY
- Kynurenines in the mammalian brain: when physiology meets pathology
- (2012) Robert Schwarcz et al. NATURE REVIEWS NEUROSCIENCE
- The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
- (2011) Susanna Campesan et al. CURRENT BIOLOGY
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Levodopa in the treatment of Parkinson’s disease
- (2009) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington’s disease
- (2009) Caroline M. Forrest et al. JOURNAL OF NEUROCHEMISTRY
- Metabolomic Profiling in LRRK2-Related Parkinson's Disease
- (2009) Krisztina K. Johansen et al. PLoS One
- Antagonizing L-type Ca2+ Channel Reduces Development of Abnormal Involuntary Movement in the Rat Model of L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia
- (2008) Stefan Schuster et al. BIOLOGICAL PSYCHIATRY
- Metabolomic profiling to develop blood biomarkers for Parkinson's disease
- (2008) M. Bogdanov et al. BRAIN
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum
- (2008) L. Amori et al. NEUROSCIENCE
- Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys
- (2007) L GREGOIRE et al. BEHAVIOURAL BRAIN RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started